2074 related articles for article (PubMed ID: 19296420)
1. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
2. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Lynch JP; Zhanel GG
Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
5. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
6. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
7. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
Liñares J; Ardanuy C; Pallares R; Fenoll A
Clin Microbiol Infect; 2010 May; 16(5):402-10. PubMed ID: 20132251
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
10. The antimicrobial resistance profile of Streptococcus pneumoniae.
Reinert RR
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
[TBL] [Abstract][Full Text] [Related]
14. Resistance among Streptococcus pneumoniae: Implications for drug selection.
Appelbaum PC
Clin Infect Dis; 2002 Jun; 34(12):1613-20. PubMed ID: 12032897
[TBL] [Abstract][Full Text] [Related]
15. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia.
Fogarty C; Torres A; Choudhri S; Haverstock D; Herrington J; Ambler J
Int J Clin Pract; 2005 Nov; 59(11):1253-9. PubMed ID: 16236076
[TBL] [Abstract][Full Text] [Related]
17. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs].
Mihajlović-Ukropina M; Milutinović M
Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of antibiotic resistance in respiratory tract infections.
Klugman KP
Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
